CGON
CG Oncology·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CGON fundamentals
CG Oncology (CGON) released its earnings on Nov 14, 2025: revenue was 1.67M (YoY +3774.42%), beat estimates; EPS was -0.57 (YoY -90.00%), missed estimates.
Revenue / YoY
1.67M
+3774.42%
EPS / YoY
-0.57
-90.00%
Report date
Nov 14, 2025
EPS
Revenue
Revenue & Expenses
CGON has released its 2025 Q3 earnings report, with revenue of 1.67M, reflecting a YoY change of 3774.42%, and net profit of -43.81M, showing a YoY change of -114.69%. The Sankey diagram below clearly presents CGON's revenue sources and cost distribution.
Key Indicators
CG Oncology (CGON) key financial stats and ratios, covering profitability, financial health, and leverage.
CG Oncology (CGON)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
CG Oncology (CGON)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
CG Oncology (CGON)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does CG Oncology (CGON) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track CG Oncology (CGON) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in CG Oncology's revenue and profit?What were the key takeaways from CG Oncology’s earnings call?What is the revenue and EPS growth rate for CG Oncology year over year?What were the key takeaways from CG Oncology's earnings call?What is CG Oncology's latest dividend and current dividend yield?Did CG Oncology beat or miss consensus estimates last quarter?What is the market's earnings forecast for CG Oncology next quarter?What is CG Oncology's gross profit margin?
